738615-58-2

Upstream product

• 110-91-8 morpholine 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 583845-15-2 tert-butyl 2-{4-[(acetylamino)methyl]benzyl}-1-hydrazine carboxylate 
• 497164-30-4 tert-butyl N'-{1-[4-(acetylamino-methyl)phenyl]-meth-(E)-ylidene}-1-hydrazine carboxylate 
• 738615-92-4 N-(4-(1,3-dioxolan-2-yl)benzyl)acetamide 
• 156866-50-1 N-[(4-formylphenyl)methyl]acetamide 
• 104566-44-1 4-(1,3-dioxacyclopent-2-yl)benzylamine 
• 105-07-7 4-cyanobenzaldehyde 
• 66739-89-7 4-(1,3-dioxolan-2-yl)benzonitrile 

Downstream Products

• 738615-60-6 N-(4-{[1-(4-morpholinylcarbonyl)-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 

Relevant academic research and scientific papers

Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position

Design, synthesis and biological evaluation of a series of novel non-covalent azaphenylalanine thrombin inhibitors are presented. Replacement of the basic benzamidine moiety in azaphenylalanine derivatives by benzylamine (P1 part of a molecule) and the in

AZAPHENYLALANINE DERIVATIVES AND THEIR USE AS ANTITHROMBOTIC AGENTS

Novel azaphenylalanine derivatives of the formula I and pharmaceutically acceptable salts thereof are described wherein the substituents have the meanings as specified in the description. The compounds are useful as anticoagulants.